Drug makers hold negative view on drug re-categorization

Pharmaceutical companies expressed a negative view toward the idea of re-categorizing medicines as part of measures to reduce customers' inconvenience in buying drugs and strengthen monitoring of drug use.

The reaction came after the Korea Food and Drug Association (KFDA) Monday announced it has initially re-categorized six medicines.

Currently, drugs are classified into two categories – ...